Skip to content
Screener

Net margin at other companies

IAR
Integra LifeSciencesIART
-0.4%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-71.6%+8.8pp
iRadimed logo
iRadimedIRMD
27.4%+1.0pp
Teladoc Health logo
Teladoc HealthTDOC
-7.1%-0.8pp
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
-7.3%-3.1pp
ICU Medical logo
ICU MedicalICUI
-0.3%-0.2pp

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%
P/S+0.9×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574

FAQ

What is CeriBell, Inc.'s net margin?
CeriBell, Inc. (CBLL) reported net margin of -64.7% in Q2 2026.
How has CeriBell, Inc.'s net margin changed year-over-year?
CeriBell, Inc.'s net margin decreased by 1.4% year-over-year, from -63.8% to -64.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about CeriBell, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude